Abstract
Endovascular abdominal aortic aneurysm repair (EVAR) is a safe and efficacious treatment for both unruptured and ruptured abdominal aortic aneurysms. While perioperative mortality is lower with EVAR, long-term outcomes are similar between EVAR and open repair, including quality of life and cost-effectiveness. We review the long-term outcomes from the EUROSTAR registry, and DREAM, EVAR 1, and OVER trials.
Keywords:
EVAR; aneurysm; aortic; endovascular; long-term; outcome.
MeSH terms
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Aortic Aneurysm, Abdominal / economics
-
Aortic Aneurysm, Abdominal / mortality
-
Aortic Aneurysm, Abdominal / surgery*
-
Aortic Rupture / economics
-
Aortic Rupture / mortality
-
Aortic Rupture / surgery*
-
Blood Vessel Prosthesis Implantation* / adverse effects
-
Blood Vessel Prosthesis Implantation* / economics
-
Blood Vessel Prosthesis Implantation* / mortality
-
Clinical Trials as Topic
-
Cost-Benefit Analysis
-
Endovascular Procedures* / adverse effects
-
Endovascular Procedures* / economics
-
Endovascular Procedures* / mortality
-
Health Care Costs
-
Humans
-
Middle Aged
-
Quality of Life
-
Registries
-
Risk Factors
-
Time Factors
-
Treatment Outcome